upper
airway
consist
mainli
nasoand
oropharynx
first
point
contact
respiratori
system
microbi
organ
ubiquit
environ
evolv
highli
specialis
function
address
constant
threat
whilst
facilit
seamless
respiratori
exchang
lower
respiratori
tract
dysregul
critic
homeostat
defenc
function
lead
ingress
pathogen
lower
respiratori
tract
potenti
lead
seriou
ill
systemswid
proteom
tool
may
facilit
better
understand
mechan
upper
airway
health
diseas
studi
aim
develop
mass
spectrometri
base
proteom
method
character
upper
airway
proteom
nasoand
oropharyng
swab
sampl
use
experi
elut
univers
transport
media
utm
contain
significantli
high
level
bovin
serum
albumin
proteom
experi
test
optim
approach
character
airway
proteom
swab
sampl
elut
utm
base
number
protein
identifi
without
bsa
deplet
total
proteom
protocol
deplet
use
commerci
kit
allprep
qiagen
cellular
proteom
protocol
b
ci
cii
observ
lesson
drawn
protocol
fed
design
implement
protocol
b
b
protocol
ci
final
cii
label
free
proteom
quantif
use
protocol
n
b
n
commerci
tmt
reagent
use
protocol
ci
ii
n
protocol
ci
ii
carri
similar
condit
except
elut
gradient
h
h
respect
swab
sampl
test
studi
infant
children
without
upper
respiratori
tract
infect
kilifi
counti
hospit
kenyan
coast
protocol
least
number
protein
identifi
b
produc
highest
number
protein
identif
protocol
b
modifi
sampl
multiplex
tmt
enabl
higher
throughput
protocol
ci
number
protein
identifi
reduc
modif
protocol
ci
increas
peptid
elut
time
gener
protocol
cii
substanti
increas
number
protein
identifi
coeffici
variat
among
tmt
run
protocol
cii
substanti
overlap
ident
protein
use
four
protocol
method
abl
identifi
marker
protein
characterist
express
upper
airway
found
high
express
level
signatur
nasopharyng
oral
protein
includ
well
high
abund
protein
relat
innat
adapt
immun
function
upper
airway
develop
sensit
systemslevel
proteom
assay
systemat
quantif
nasooropharyng
protein
assay
advanc
mechanist
studi
respiratori
patholog
provid
untarget
hypothesisfre
approach
examin
airway
proteom
human
nasooropharynx
constitut
first
line
mechan
immunolog
defenc
infecti
pathogen
particul
pollut
air
pathogen
commens
microorgan
constantli
interact
cell
upper
airway
order
maintain
homeostasi
human
evolv
complex
dynam
defenc
mechan
maintain
function
mucos
barrier
barrier
regul
microbi
colonis
maintain
potent
immunolog
defenc
pathogen
microorgan
effector
function
underpin
regulatori
role
product
airway
proteom
deriv
mainli
epitheli
cell
well
innat
adapt
immun
cell
part
regulatori
mechan
incipi
antigen
initi
expel
nonimmunolog
mechan
mucu
entrap
enzymat
degrad
mechan
egress
via
mucociliari
action
endosom
degrad
phagocyt
neutrophil
macrophag
well
nonspecif
immunolog
mechan
complement
activ
may
employ
antigen
persist
final
layer
immunolog
defenc
upper
airway
consist
adapt
immun
respons
antibodi
respons
specif
tailor
specif
pathogen
spite
crucial
role
mainten
airway
health
proteom
nasooropharynx
remain
poorli
studi
particularli
infant
children
seriou
respiratori
infect
nasooropharynx
secret
provid
excel
resourc
identifi
potenti
biomark
diseas
could
contribut
substanti
understand
mechan
airway
diseas
mass
spectrometrybas
proteom
combin
comput
analysi
becom
power
tool
largescal
systemat
investig
biolog
process
untarget
hypothesisfre
approach
proteom
employ
profil
nasal
caviti
mucou
proteom
gener
well
investig
airway
diseas
allerg
rhiniti
chronic
rhinosinus
cystic
fibrosi
addit
notabl
mass
spectrometri
platform
use
investig
protein
express
studi
may
previous
lack
suffici
sensit
necessari
extens
proteom
coverag
would
help
elucid
import
biomark
mechan
prognosi
studi
develop
highthroughput
swab
proteom
workflow
use
investig
airway
proteom
infant
children
seriou
respiratori
ill
especi
hospit
field
sampl
studi
popul
sampl
procedur
nasooropharyng
sampl
collect
use
nasal
oropharyng
npop
swab
copan
diagnost
usa
elut
ml
univers
transport
media
utm
copan
diagnost
usa
supplement
proteindnarna
preserv
allprotect
qiagen
germani
upon
collect
sampl
store
studi
popul
consist
total
infant
young
children
admit
kilifi
counti
hospit
coastal
kenya
respiratori
infect
control
infant
sampl
home
exhibit
respiratori
symptom
protocol
n
protocol
b
n
protocol
c
n
diagnosi
respiratori
infect
done
use
multiplex
pcr
design
detect
respiratori
pathogen
respiratori
syncyti
viru
rsv
b
rhinoviru
parainfluenza
viru
adenoviru
influenza
b
c
coronaviru
human
metapneumoviru
mycoplasma
pneumonia
written
inform
consent
sought
parent
legal
guardian
recruit
prior
sampl
ethic
clearanc
conduct
studi
provid
kenya
medic
research
institut
kemri
scientif
ethic
review
committe
seru
method
perform
accord
good
clinic
laboratori
practic
gclp
guidelin
overview
protocol
develop
analysi
upperairway
proteom
proteom
experi
test
optim
approach
character
airway
proteom
swab
sampl
elut
utm
base
number
protein
identifi
protocol
develop
test
stepwis
sequenc
observ
lesson
drawn
one
protocol
feed
design
implement
next
first
protocol
test
base
six
randomli
select
patient
sampl
lyse
urea
peptid
gener
use
standard
workflow
analys
label
free
quantif
second
protocol
b
nasal
sampl
four
randomli
select
children
select
cell
obtain
centrifug
cell
lyse
total
protein
extract
lysat
use
commerci
kit
allprep
qiagen
peptid
gener
analys
label
free
quantif
third
fourth
protocol
ci
cii
sampl
select
children
protocol
c
protein
peptid
prepar
manner
protocol
b
peptid
label
isobar
mass
tag
protocol
ci
ii
carri
similar
condit
except
elut
gradient
h
h
respect
schemat
outlin
protocol
shown
fig
detail
descript
individu
protocol
outlin
supplementari
method
mass
spectrometri
analysi
peptid
load
use
dionex
ultim
nanoflow
ultrahighpressur
liquid
chromatographi
system
thermo
scientif
usa
cm
trap
column
thermo
scientif
usa
separ
cm
reversephas
analyt
column
thermo
scientif
heat
lfq
protein
quantif
elut
carri
mobil
phase
b
acetonitril
formic
acid
gradient
min
flow
rate
tmt
protein
quantif
two
gradient
employ
protocol
c
gradient
similar
use
lfq
protein
quantif
gradient
employ
protocol
c
ii
modifi
elut
peptid
min
lc
run
finish
washout
b
min
reequilibr
b
min
five
blank
min
run
column
inject
compris
two
wash
cycl
b
equilibr
phase
min
avoid
sampl
carryov
peptid
measur
use
q
exact
orbitrap
mass
spectromet
thermo
scientif
usa
coupl
chromatographi
system
via
nanoelectrospray
ion
sourc
thermo
scientif
q
exact
set
peptid
resolut
agc
target
maximum
ms
scan
rang
mz
set
fragment
spectra
peptid
resolut
label
peptid
agc
target
maximum
ms
isol
scientif
report
window
mz
ms
data
acquir
data
depend
acquisit
top
label
peptid
intens
precursor
ion
posit
mode
select
higherenergi
ctrap
dissoci
fragment
subsequ
exclud
next
follow
fragment
event
charg
exclus
set
ignor
peptid
spectrum
match
unassign
singli
charg
charg
lfq
protein
quantif
cystein
carbamidomethyl
set
fix
modif
ntermin
acetyl
methionin
oxid
variabl
modif
fals
discoveri
rate
fdr
set
protein
peptidespectrum
match
determin
search
fasta
protein
databas
compris
target
revers
target
sequec
decoy
deriv
organ
studi
switch
aminocarboxyl
orient
protein
amino
acid
gener
sequenc
exist
natur
enzym
specif
set
ctermin
arginin
lysin
trypsin
proteas
maximum
two
miss
cleavag
allow
databas
search
peptid
identif
perform
allow
initi
precursor
mass
deviat
ppm
allow
fragment
mass
deviat
ppm
minimum
peptid
length
amino
acid
maximum
peptid
mass
da
allow
search
label
free
quantif
lfq
algorithm
maxquant
use
obtain
quantif
intens
valu
label
protein
quantif
tmt
specifi
isobar
label
report
ion
report
mass
toler
set
da
carbamidomethyl
c
label
nterminu
lysin
set
fix
modif
oxid
acetyl
protein
nterm
variabl
figur
schemat
overview
nasooropharyng
proteom
experi
nasoand
oropharyng
swab
collect
infant
elut
univers
transport
media
supplement
proteindnarna
preserv
one
set
sampl
protocol
cell
utm
lyse
urea
reduc
alkyl
digest
trypsin
peptid
separ
hplc
elut
h
gradient
prior
ms
analysi
anoth
set
sampl
protocol
b
c
cell
utm
pellet
centrifug
lyse
protein
extract
use
commerci
extract
kit
protein
reduc
alkyl
digest
trypsin
protocol
b
peptid
separ
hplc
elut
h
gradient
protocol
c
peptid
label
use
tmt
isobar
mass
tag
pool
togeth
prior
hplc
separ
protocol
ci
protein
elut
h
gradient
protocol
cii
protein
elut
h
gradient
prior
ms
analysi
scientif
report
modif
type
modif
use
protein
quantif
report
ion
intens
matrix
studi
particip
extract
maxquant
proteingroup
matrix
file
batch
correct
use
hous
platform
assayperform
perform
four
test
protocol
base
number
protein
identifi
protocol
well
presenc
marker
protein
known
express
cell
upper
respiratori
tract
four
protocol
protocol
b
protein
extract
patient
sampl
use
commerci
proteindnarna
extract
kit
follow
label
free
quantif
result
highest
number
protein
identif
fig
protocol
sampl
lyse
urea
reduc
alkyl
digest
follow
labelfre
quantif
result
lowest
number
protein
identif
protocol
c
compris
two
subprotocol
distinguish
elut
gradient
result
intermedi
number
identif
although
protocol
cii
protein
extract
use
commerci
extract
kit
peptid
label
tmt
tag
subsequ
elut
gradient
yield
substanti
increas
protein
identif
protocol
ci
three
protocol
yield
highest
number
protein
identif
protocol
b
ci
cii
substanti
overlap
ident
protein
detect
three
method
shown
fig
analysi
assay
stabil
reproduc
restrict
sampl
protocol
cii
deem
practic
routin
applic
due
capac
multiplex
superior
perform
protein
identif
compar
protocol
ci
interbatch
correl
total
proteom
pool
control
sampl
carri
calcul
pairwis
pearson
correl
coeffici
batch
shown
fig
high
degre
correl
batch
median
pearson
r
valu
fig
random
select
protein
dsp
whose
median
express
level
spread
across
entir
dynam
rang
protocol
cii
show
express
level
protein
remain
rel
stabl
across
experiment
batch
fig
cellspecif
marker
protein
analysi
order
characteris
proteom
identifi
protocol
cii
express
signatur
protein
typic
express
upperairway
cell
assess
high
express
level
signatur
nasopharyng
protein
note
fig
coeffici
variat
protein
well
protein
pool
control
less
fig
addit
mucin
major
compon
mucin
secret
ubiquit
coat
mucos
surfac
respiratori
tract
express
high
level
nasopharyng
secret
infant
studi
fig
two
highli
express
protein
nasooropharyng
proteom
signatur
mucos
epithelia
keratin
keratin
keratin
fig
addit
nasopharyng
marker
protein
also
note
high
express
level
definit
oralsalivari
protein
salivari
amylas
sampl
analys
fig
protein
polymer
immunoglobulin
receptor
pigr
protein
mediat
activ
transcytosi
secretori
immunoglobulin
onto
lumin
surfac
respiratori
tract
express
high
level
patient
sampl
analys
fig
addit
protein
whose
origin
could
attribut
resid
epitheli
cell
note
presenc
protein
secret
nonepitheli
cell
evalu
express
level
differ
set
protein
stratifi
put
origin
includ
acut
phase
protein
app
antimicrobi
peptid
amp
immunoglobulin
protein
milk
protein
protein
associ
effector
function
phagocyt
cell
high
degre
heterogen
express
level
acut
phase
protein
median
express
level
haptoglobin
hp
highest
categori
creactiv
protein
crp
lowest
median
express
level
among
app
analys
fig
first
panel
similarli
divers
pattern
express
also
observ
among
antimicrobi
peptid
cathepsin
g
ctsg
abund
amp
alpha
defensin
express
much
lower
level
fig
second
panel
addit
app
amp
extrem
high
express
level
immunoglobulin
heavi
chain
alpha
gamma
mu
observ
nasooropharyng
secret
children
studi
although
iga
heavi
chain
express
much
lower
level
compar
immunoglobulin
subclass
heavi
chain
fig
third
panel
final
set
immunerel
protein
associ
effector
function
phagocyt
cell
neutrophil
macrophag
fig
fifth
panel
three
protein
categori
lactotransferrin
ltf
calcium
zinc
bind
protein
compon
calprotectin
myeloperoxidas
mpo
among
highli
express
protein
entir
nasooropharyng
proteom
fig
respect
median
express
level
exceed
cytoskelet
microfibrillar
mucos
keratin
betaactin
actb
addit
host
protein
also
identifi
high
level
nonhost
protein
respiratori
tract
highli
express
three
milk
protein
lactalbumin
alpha
lalba
beta
casein
kappa
casein
fig
fourth
panel
valid
whether
milk
protein
human
bovin
origin
carri
determin
age
correl
protein
respect
express
level
top
three
protein
function
categori
plot
age
studi
particip
fig
except
milk
protein
systemat
chang
protein
express
level
could
associ
increas
age
case
milk
protein
three
appear
abund
first
month
life
precipit
declin
later
year
observ
fig
fourth
panel
final
investig
express
select
tcell
associ
proinflammatori
protein
interferon
tcell
phenotyp
marker
associ
effector
protein
granzym
detect
nasooropharyng
proteom
studi
subject
use
data
protocol
cii
undertook
ordin
analysi
visual
whether
proteom
children
respiratori
infect
vari
sever
healthi
control
sampl
home
vari
use
nonmetr
multidimension
scale
found
airway
proteom
children
admit
hospit
sever
respiratori
infect
mild
infect
warrant
hospitalis
larg
overlap
supplementari
figur
howev
proteom
healthi
control
children
sampl
home
cluster
separ
respiratori
infect
describ
develop
comprehens
method
analys
nasooropharyng
proteom
infant
young
children
respiratori
ill
four
protein
identif
method
report
highest
number
protein
identif
achiev
use
protocol
b
method
protein
nasooropharyng
sampl
extract
use
commerci
extract
kit
follow
labelfre
quantif
howev
unlik
method
describ
protocol
c
method
limit
fact
one
sampl
analys
time
limit
practic
highthroughput
applic
protocol
ci
cii
peptid
differ
patient
sampl
label
reagent
allow
sampl
multiplex
prior
ms
analysi
follow
insilico
demultiplex
analysi
analyt
design
increas
sampl
throughput
concurr
limit
intersampl
varianc
inher
singlesampl
analysi
reason
limit
analysi
assay
sensit
stabil
reproduc
protocol
ci
cii
found
high
level
correl
control
sampl
run
differ
assay
batch
well
limit
interbatch
varianc
suggest
method
develop
suffici
robust
quantit
analysi
upperairway
proteom
order
increas
sensit
protein
identif
experi
effect
differ
elut
gradient
protein
identif
initi
set
experi
protocol
ci
peptid
elut
minut
result
protein
identif
howev
elut
time
increas
minut
protocol
cii
protein
identifi
bring
total
number
protein
identifi
protocol
cii
compar
previou
massspectrometrybas
proteom
studi
upper
airway
number
protein
identifi
protocol
cii
vastli
exceed
number
protein
report
previous
publish
report
characteris
proteom
identifi
protocol
cii
done
evalu
express
level
marker
protein
resid
nasooropharyng
epitheli
cell
inlin
recent
studi
upper
airway
transcriptom
found
consist
high
express
signatur
upperairway
protein
protein
uniqu
express
profil
restrict
trachea
nasopharyng
epithelia
salivari
gland
therefor
consid
signatur
protein
upper
airway
addit
definit
upperairway
protein
found
consist
high
level
express
mucin
main
compon
respiratori
tract
mucu
mucosalassoci
keratin
keratin
abundantli
express
protein
detect
nasooropharyng
proteom
differenti
keratin
oral
mucosa
therefor
high
level
detect
consist
anatom
locat
target
sampl
addit
upperairway
differenti
protein
found
high
express
level
number
antibodi
relat
protein
includ
polymer
immunoglobulin
receptor
pigr
pigr
type
membranespan
antibodi
fc
receptor
express
high
level
mucos
epitheli
cell
facilit
activ
transcytosi
secretori
immunoglobulin
express
pigr
link
equal
high
express
immunoglobulin
heavi
chain
alpha
iga
mu
igm
gamma
igg
associ
align
known
biolog
function
pigr
like
indic
role
maintain
high
level
antibodi
mucos
surfac
also
examin
secretom
immun
cell
airway
found
larg
number
protein
associ
innat
immun
case
express
high
level
exampl
express
level
neutrophil
antimicrobi
effector
protein
ltf
mpo
among
highest
entir
nasooropharyng
proteom
also
present
upperairway
proteom
child
studi
observ
overabund
protein
protein
well
other
also
relat
antimicrobi
immun
like
ctsg
camp
like
relat
need
prevent
bacteri
overgrowth
maintain
homeostat
balanc
upper
respiratori
tract
previou
studi
provid
compel
evid
function
role
protein
ltf
camp
ctsg
other
limit
bacteri
replic
presenc
protein
high
level
detect
support
notion
play
key
role
regul
level
commens
microbiota
henc
prevent
bacteri
overgrowth
could
result
patholog
interestingli
also
note
high
level
milk
protein
lactalbumin
alpha
lalba
alpha
kappa
casein
protein
present
highest
level
first
month
life
declin
second
half
first
year
life
children
age
month
rel
low
level
milk
protein
upper
airway
taken
togeth
observ
consist
fact
infant
age
six
month
predominantli
breastf
declin
milkprotein
level
six
month
like
associ
wean
precipit
declin
observ
first
year
life
like
reflect
complet
cessat
breast
feed
final
use
ordin
analysi
compar
airway
proteom
children
differ
clinic
manifest
respiratori
ill
healthi
children
sampl
home
proteom
children
respiratori
infect
cluster
separ
well
children
distinct
like
attribut
host
innat
inflammatori
respons
mount
host
order
address
ongo
infect
respons
would
absent
well
control
absenc
clinic
symptom
time
sampl
indic
absenc
intens
inflammatori
respons
search
tcell
associ
marker
effector
protein
identifi
protein
upperairway
proteom
children
studi
cell
effector
cytokin
chemokin
ifng
mediat
wide
report
studi
paediatr
upper
airway
secret
use
sensit
immunoassay
luminex
msd
mesoscal
absenc
mediat
studi
suggest
possibl
limit
method
report
paper
failur
identifi
low
abund
protein
upper
airway
proteom
spite
shortcom
msbase
method
report
offer
great
advantag
target
approach
provid
unbias
hypothesisfre
overview
upperairway
proteom
therebi
increas
likelihood
identifi
novel
associ
diseas
patholog
data
analysi
done
use
r
cluster
analysi
determin
differ
protein
express
children
respiratori
infect
healthi
control
done
use
nonmetr
multidomension
scale
analysi
access
number
data
report
paper
proteomexchang
